These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 28599244

  • 1. CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin.
    Coskun ZM, Koyuturk M, Karabulut S, Bolkent S.
    Pharmacol Rep; 2017 Aug; 69(4):822-829. PubMed ID: 28599244
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats.
    Karabulut S, Coskun ZM, Bolkent S.
    Pharmacol Rep; 2015 Oct; 67(5):846-53. PubMed ID: 26398375
    [Abstract] [Full Text] [Related]

  • 3. Effect of siglidine on glucose lipid metabolism and the expression of iNOS and GLP-1 receptors in diabetic rats.
    Zhang HY, Li Y, Zhong YH, Ruan LB, Yang TR, Yin HP.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8984-8989. PubMed ID: 30575943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.
    Tang ST, Su H, Zhang Q, Tang HQ, Wang CJ, Zhou Q, Wei W, Zhu HQ, Wang Y.
    Int J Mol Med; 2016 Jun; 37(6):1558-66. PubMed ID: 27122056
    [Abstract] [Full Text] [Related]

  • 6. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
    Eitah HE, Maklad YA, Abdelkader NF, Gamal El Din AA, Badawi MA, Kenawy SA.
    Toxicol Appl Pharmacol; 2019 Feb 15; 365():30-40. PubMed ID: 30576699
    [Abstract] [Full Text] [Related]

  • 7. Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury.
    Han W, Li Y, Cheng J, Zhang J, Chen D, Fang M, Xiang G, Wu Y, Zhang H, Xu K, Wang H, Xie L, Xiao J.
    J Cell Mol Med; 2020 Aug 15; 24(15):8687-8702. PubMed ID: 32573108
    [Abstract] [Full Text] [Related]

  • 8. Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner.
    Khedr RM, Ahmed AAE, Kamel R, Raafat EM.
    Life Sci; 2018 Oct 15; 211():31-39. PubMed ID: 30195035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
    Marques C, Gonçalves A, Pereira PMR, Almeida D, Martins B, Fontes-Ribeiro C, Reis F, Fernandes R.
    Life Sci; 2019 Oct 01; 234():116738. PubMed ID: 31398418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Li B, Luo YR, Zhang Q, Fu SH, Chen YD, Tian JW, Guo Y.
    Vascul Pharmacol; 2021 Oct 01; 140():106854. PubMed ID: 33781961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats.
    Akarte AS, Srinivasan BP, Gandhi S, Sole S.
    Eur J Pharm Sci; 2012 Sep 29; 47(2):456-63. PubMed ID: 22800967
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model.
    Campos EJ, Martins J, Brudzewsky D, Woldbye DPD, Ambrósio AF.
    Ann Anat; 2020 Jan 29; 227():151419. PubMed ID: 31563570
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y, Liu Y, Xu J, Sun Q, Yu F, Cheng J, Peng B, Liu W, Xiao Z, Yin J, Han S, He X.
    Biochem Pharmacol; 2018 Oct 29; 156():78-85. PubMed ID: 30086287
    [Abstract] [Full Text] [Related]

  • 19. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y, Wang Q, Zhang J, Lei X, Xu GT, Ye W.
    Graefes Arch Clin Exp Ophthalmol; 2009 May 29; 247(5):699-706. PubMed ID: 19084986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.